Rchr
J-GLOBAL ID:201501017289339120   Update date: Dec. 15, 2020

Hasumi Hisashi

ハスミ ヒサシ | Hasumi Hisashi
Affiliation and department:
Homepage URL  (1): http://www-user.yokohama-cu.ac.jp/~urology/wp/
Research field  (1): Urology
Research keywords  (3): Familial Cancer Syndrome ,  Kidney Cancer ,  Urologic Surgery
Papers (58):
  • Ikue Tai-Nagara, Yukiko Hasumi, Dai Kusumoto, Hisashi Hasumi, Keisuke Okabe, Tomofumi Ando, Fumio Matsuzaki, Fumiko Itoh, Hideyuki Saya, Chang Liu, et al. Blood and lymphatic systems are segregated by the FLCN tumor suppressor. Nature communications. 2020. 11. 1. 6314-6314
  • Mitsuko Furuya, Yasuhiro Iribe, Yoji Nagashima, Naotomo Kambe, Chisato Ohe, Hidefumi Kinoshita, Chika Sato, Takeshi Kishida, Yoichiro Okubo, Kazuyuki Numakura, et al. Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas. Journal of clinical pathology. 2020. 73. 12. 819-825
  • Narihiko Hayashi, Kimito Osaka, Kentaro Muraoka, Hisashi Hasumi, Kazuhide Makiyama, Keiichi Kondo, Noboru Nakaigawa, Masahiro Yao, Yuki Mukai, Madoka Sugiura, et al. Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis. World journal of urology. 2020. 38. 10. 2477-2484
  • Yasuhiro Iribe, Mitsuko Furuya, Yousuke Shibata, Masato Yasui, Makoto Funahashi, Junichi Ota, Hiromichi Iwashita, Yoji Nagashima, Hisashi Hasumi, Narihiko Hayashi, et al. Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report. Familial cancer. 2020
  • Go Noguchi, Noboru Nakaigawa, Susumu Umemoto, Kota Kobayashi, Yosuke Shibata, Sohgo Tsutsumi, Masato Yasui, Shinji Ohtake, Takahisa Suzuki, Kimito Osaka, et al. C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma. Cancer chemotherapy and pharmacology. 2020. 86. 1. 75-85
more...
MISC (250):
Professional career (1):
  • M.D. (Yokohama City University)
Awards (5):
  • 2019 - International Journal of Urology, Top Cited Article 2018
  • 2018/06 - The 24th Annual Meeting of the Japanese Society for Familial Tumors Best Title Award
  • 2011/05 - Myrovlytis Trust Travel award
  • 2010 - Gene, Top Cited Article 2008-2010
  • 2008/09 - Myrovlytis Trust Travel award
Association Membership(s) (3):
THE JAPANESE SOCIETY FOR FAMILIAL TUMORS ,  JAPANESE SOCIETY OF ENDOUROLOGY ,  THE JAPANESE UROLOGICAL ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page